New injection targets hidden heart risk factor
Disease control
Recruiting now
This study is testing whether an experimental injection called Kylo-11 can safely lower high levels of lipoprotein(a), a fatty particle in the blood linked to heart disease. About 204 adults with existing heart disease and elevated lipoprotein(a) will receive either Kylo-11 or a …
Phase: PHASE2 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC